| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |